JFNIX
Price
$70.64
Change
+$0.56 (+0.80%)
Updated
Sep 5 closing price
Net Assets
4.28B
LHCVX
Price
$20.06
Change
+$0.11 (+0.55%)
Updated
Sep 4 closing price
Net Assets
7.8M
Interact to see
Advertisement

JFNIX vs LHCVX

Header iconJFNIX vs LHCVX Comparison
Open Charts JFNIX vs LHCVXBanner chart's image
Janus Henderson Global Life Sciences I
Price$70.64
Change+$0.56 (+0.80%)
VolumeN/A
Net Assets4.28B
Lord Abbett Health Care R6
Price$20.06
Change+$0.11 (+0.55%)
VolumeN/A
Net Assets7.8M
JFNIX vs LHCVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFNIX vs. LHCVX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and LHCVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.29B vs. LHCVX (7.8M). LHCVX pays higher dividends than JFNIX: LHCVX (0.55) vs JFNIX (0.39). JFNIX was incepted earlier than LHCVX: JFNIX (16 years) vs LHCVX (6 years). LHCVX (2.99) is less costly to investors than JFNIX (0.77). LHCVX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). LHCVX has a lower initial minimum investment than JFNIX: LHCVX (0) vs JFNIX (2500). LHCVX annual gain was more profitable for investors over the last year : -0.84 vs. JFNIX (-12.88). LHCVX return over 5 years is better than : 11.35 vs. JFNIX (10.19).
JFNIXLHCVXJFNIX / LHCVX
Total Expense Ratio0.770.68113%
Annual Report Gross Expense Ratio0.772.9926%
Fund Existence16 years6 years-
Gain YTD3.8523.809101%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.29B7.8M54,964%
Annual Yield % from dividends0.390.5570%
Returns for 1 year-12.88-0.841,529%
Returns for 3 years17.0220.1385%
Returns for 5 years10.1911.3590%
Returns for 10 years22.06N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJPTX14.960.14
+0.94%
VY® JPMorgan Emerging Markets Equity S2
PGLEX19.150.09
+0.47%
Putnam Focused International Equity R6
FFANX13.970.04
+0.29%
Fidelity Asset Manager 40%
OMGCX27.10N/A
N/A
JPMorgan Mid Cap Growth C
AFAVX14.42N/A
N/A
AMG River Road Focused Absolute Value I